Performance of a commercial immunoglobulin M antibody capture assay using analyte-specific reagents to screen for interfering factors during a West Nile virus epidemic season in Nebraska
- PMID: 17121982
- PMCID: PMC1797711
- DOI: 10.1128/CVI.00272-06
Performance of a commercial immunoglobulin M antibody capture assay using analyte-specific reagents to screen for interfering factors during a West Nile virus epidemic season in Nebraska
Abstract
In 2003, the Nebraska Public Health Laboratory tested more than 10,371 serum and 516 cerebral spinal fluid specimens. Results showed that without performing the interfering factors screen for specimens in the low positive index value range of >1.1 to <or=3.5, a false positivity rate of 6.5% would have been realized.
References
-
- Altman, D. G. 1999. Practical statistics for medical research, p. 404-408. Chapman and Hall, London, United Kingdom.
-
- Beatty, B. J., C. H. Calisher, and R. E. Shope. 1995. Arboviruses, p. 189-202. In E. H. Lennette, D. A. Lennette, and E. T. Lennette (ed.), Diagnostic procedures for viral, rickettsial, and chlamydial infections. American Public Health Association, Washington, DC.
-
- Cremer, N. E., and J. L. Riggs. 1979. Immunoglobulin classes and viral diagnosis, p. 191-208. In E. H. Lennette and N. J. Schmidt (ed.), Diagnostic procedures for viral, rickettsial, and chlamydial infections, 5th ed. American Public Health Association, Washington, DC.
-
- Huebner, J. 2004. Antibody-antigen interactions and measurements of immunologic reactions, p. 207-232. In G. Pier, J. Lyczak, and L. Wetzler (ed.), Immunology, infection, and immunity. ASM Press, Washington, DC.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
